200 related articles for article (PubMed ID: 32763140)
1. Concise Chemoenzymatic Total Synthesis and Identification of Cellular Targets of Cepafungin I.
Amatuni A; Shuster A; Adibekian A; Renata H
Cell Chem Biol; 2020 Oct; 27(10):1318-1326.e18. PubMed ID: 32763140
[TBL] [Abstract][Full Text] [Related]
2. Modulation of proteasome subunit selectivity of syringolins.
Tatsumi K; Kitahata S; Komatani Y; Katsuyama A; Yakushiji F; Ichikawa S
Bioorg Med Chem; 2024 May; 106():117733. PubMed ID: 38704960
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Activity of Isosyringolin A.
Kitahata S; Chiba T; Yoshida T; Ri M; Iida S; Matsuda A; Ichikawa S
Org Lett; 2016 May; 18(9):2312-5. PubMed ID: 27123978
[TBL] [Abstract][Full Text] [Related]
4. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Structure-Activity Relationship Studies of Cepafungin Enabled by Biocatalytic C-H Oxidations.
Amatuni A; Shuster A; Abegg D; Adibekian A; Renata H
ACS Cent Sci; 2023 Feb; 9(2):239-251. PubMed ID: 36844499
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome.
Sun Q; Zhou T; Xi D; Li X; Lü Z; Xu F; Wang C; Niu Y; Xu P
Eur J Med Chem; 2020 Apr; 192():112160. PubMed ID: 32146375
[TBL] [Abstract][Full Text] [Related]
7. Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.
Marastoni M; Trapella C; Scotti A; Fantinati A; Ferretti V; Marzola E; Eleonora G; Gavioli R; Preti D
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):865-877. PubMed ID: 28657369
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors.
Yang Y; Wang K; Wu B; Yang Y; Lai F; Chen X; Xiao Z
Bioorg Med Chem Lett; 2020 Nov; 30(21):127508. PubMed ID: 32853683
[TBL] [Abstract][Full Text] [Related]
9. One-shot NMR analysis of microbial secretions identifies highly potent proteasome inhibitor.
Stein ML; Beck P; Kaiser M; Dudler R; Becker CF; Groll M
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18367-71. PubMed ID: 23091006
[TBL] [Abstract][Full Text] [Related]
10. Identification of potent and selective non-covalent inhibitors of the Plasmodium falciparum proteasome.
Li H; Tsu C; Blackburn C; Li G; Hales P; Dick L; Bogyo M
J Am Chem Soc; 2014 Oct; 136(39):13562-5. PubMed ID: 25226494
[TBL] [Abstract][Full Text] [Related]
11. Macrocyclic Peptides that Selectively Inhibit the
Zhang H; Hsu HC; Kahne SC; Hara R; Zhan W; Jiang X; Burns-Huang K; Ouellette T; Imaeda T; Okamoto R; Kawasaki M; Michino M; Wong TT; Toita A; Yukawa T; Moraca F; Vendome J; Saha P; Sato K; Aso K; Ginn J; Meinke PT; Foley M; Nathan CF; Darwin KH; Li H; Lin G
J Med Chem; 2021 May; 64(9):6262-6272. PubMed ID: 33949190
[TBL] [Abstract][Full Text] [Related]
12. 20S proteasome as novel biological target for organochalcogenanes.
Piovan L; Milani P; Silva MS; Moraes PG; Demasi M; Andrade LH
Eur J Med Chem; 2014 Feb; 73():280-5. PubMed ID: 24463395
[TBL] [Abstract][Full Text] [Related]
13. Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome.
Totaro KA; Barthelme D; Simpson PT; Jiang X; Lin G; Nathan CF; Sauer RT; Sello JK
ACS Infect Dis; 2017 Feb; 3(2):176-181. PubMed ID: 28183185
[TBL] [Abstract][Full Text] [Related]
14. Computational inhibition studies of the human proteasome by argyrin-based analogues with subunit specificity.
Loizidou EZ; Zeinalipour-Yazdi CD
Chem Biol Drug Des; 2014 Jul; 84(1):99-107. PubMed ID: 24521156
[TBL] [Abstract][Full Text] [Related]
15. Total synthesis and absolute stereochemistry of the proteasome inhibitors cystargolides A and B.
Tello-Aburto R; Hallada LP; Niroula D; Rogelj S
Org Biomol Chem; 2015 Oct; 13(40):10127-30. PubMed ID: 26400369
[TBL] [Abstract][Full Text] [Related]
16. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
[TBL] [Abstract][Full Text] [Related]
17. Peptido sulfonyl fluorides as new powerful proteasome inhibitors.
Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM
J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors.
Niroula D; Hallada LP; Le Chapelain C; Ganegamage SK; Dotson D; Rogelj S; Groll M; Tello-Aburto R
Eur J Med Chem; 2018 Sep; 157():962-977. PubMed ID: 30165344
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i).
Klein M; Busch M; Friese-Hamim M; Crosignani S; Fuchss T; Musil D; Rohdich F; Sanderson MP; Seenisamy J; Walter-Bausch G; Zanelli U; Hewitt P; Esdar C; Schadt O
J Med Chem; 2021 Jul; 64(14):10230-10245. PubMed ID: 34228444
[TBL] [Abstract][Full Text] [Related]
20. Noncovalent inhibitors of human 20S and 26S proteasome based on trypsin inhibitor SFTI-1.
Dębowski D; Cichorek M; Lubos M; Wójcik S; Łęgowska A; Rolka K
Biopolymers; 2016 Sep; 106(5):685-96. PubMed ID: 27258473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
